Tisento
Cambridge, United States · Founded 2023
- Headquarters
- Cambridge
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- tisentotherapeutics.com
- Last Round
- Series AJul 2023
- Rounds
- 1
About
Tisento Therapeutics is a committed team of industry veterans working closely with a broad network of collaborators. The company's current focus is on developing zagociguat as a treatment for individuals with MELAS, a debilitating disease with no effective treatments. Tisento's goal is to enable a better future for those living with severe diseases.
Summary
Tisento is a Biotech company based in Cambridge, United States, founded in 2023. Its most recent funding was a Series A round in Jul 2023. Investors include Venrock, Polaris Partners and Sanofi Ventures.
Funding History
Jul 2023
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tisento"><img src="https://indexed.vc/api/badge/company/tisento" alt="Tisento on Indexed.vc" width="260" height="76" /></a>